Overall survival (OS) and progression-free survival (PFS) curves illustrate the survival of all patients.
收藏数据链接：
官方服务：
资源简介：
For the whole cohort of patients with esophageal squamous cell cancer who underwent radiotherapy, the median OS and PFS were 16 months and 12 months, respectively. The 1-, 2-, and 3-year OS and PFS rates for the entire population were 62.8%, 35.0%, and 23.2%, and 47.4%, 29.1%, and 21.2%, respectively.
创建时间：
2016-02-23
